|
answer text |
<p>NHS England provides BRCA testing services for women at high risk of breast and
ovarian cancer.</p><p> </p><p> </p><p> </p><p>Following the National Institute for
Health and Care Excellence’s (NICE) updated clinical guideline on familial breast
cancer published in June 2013, NHS England is currently considering whether to widen
its offer of testing. NICE is also consulting on its draft technology appraisal guidance
on the use of the new PARP inhibiter, olaparib (Lynparza) which is targeted at BRCA
positive ovarian cancer. In addition, through initiatives like the 100,000 Genomes
Project we will in time provide more insights into personalised treatments for ovarian
cancer.</p><p> </p>
|
|